Symptomatic osteonecrosis in French survivors of childhood and adolescent leukemia: a clinical and MRI study of LEA cohort

References

• Steliarova-Foucher E, Colombet M, Ries LAG, et al. International incidence of childhood cancer, 2001-10: a population-based registry study. Lancet Oncol. 2017;18(6):719–731. doi:10.1016/S1470-2045(17)30186-9.
   PubMed Web of Science ®Google Scholar
• Pui CH, Yang JJ, Hunger SP, et al. Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol. 2015;33(27):2938–2948. doi:10.1200/JCO.2014.59.1636.
   PubMed Web of Science ®Google Scholar
• Murphy RG, Greenberg ML. Osteonecrosis in pediatric patients with acute lymphoblastic leukemia. Cancer. 1990;65(8):1717–1721. doi:10.1002/1097-0142(19900415)65:8 < 1717::aid-cncr2820650809 > 3.0.co;2-b.
   PubMed Web of Science ®Google Scholar
• Socié G, Sélimi F, Sedel L, et al. Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors. Br J Haematol. 1994;86(3):624–628. doi:10.1111/j.1365-2141.1994.tb04795.x.
   PubMed Web of Science ®Google Scholar
• Hines JT, Jo WL, Cui Q, et al. Osteonecrosis of the femoral head: an updated review of ARCO on pathogenesis, staging and treatment. J Korean Med Sci. 2021;36(24):e177. doi:10.3346/jkms.2021.36.e177.
   PubMed Web of Science ®Google Scholar
• Weinstein RS, Nicholas RW, Manolagas SC. Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab. 2000;85(8):2907–2912. doi:10.1210/jcem.85.8.6714.
   PubMed Web of Science ®Google Scholar
• Miyanishi K, Yamamoto T, Irisa T, et al. Bone marrow fat cell enlargement and a rise in intraosseous pressure in steroid-treated rabbits with osteonecrosis. Bone. 2002;30(1):185–190. doi:10.1016/S8756-3282(01)00663-9.
   PubMed Web of Science ®Google Scholar
• Mattano LA, Sather HN, Trigg ME, Nachman JB. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the children’s cancer group. J Clin Oncol. 2000;18(18):3262–3272. doi:10.1200/JCO.2000.18.18.3262.
   PubMed Web of Science ®Google Scholar
• Te Winkel ML, Pieters R, Wind EJD, Bessems J, van den Heuvel-Eibrink MM. Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia. Haematologica. 2014;99(3):430–436. doi:10.3324/haematol.2013.095562.
   PubMed Web of Science ®Google Scholar
• van den Heuvel-Eibrink MM, Pieters R. Steroids and risk of osteonecrosis in ALL: take a break. Lancet Oncol. 2012;13(9):855–857. doi:10.1016/S1470-2045(12)70315-7.
   PubMed Web of Science ®Google Scholar
• Mattano LA, Devidas M, Nachman JB, et al. Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial. Lancet Oncol. 2012;13(9):906–915. doi:10.1016/S1470-2045(12)70274-7.
   PubMed Web of Science ®Google Scholar
• Girard P, Auquier P, Barlogis V, et al. Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthood. Haematologica. 2013;98(7):1089–1097. doi:10.3324/haematol.2012.081265.
   PubMed Web of Science ®Google Scholar
• Te Winkel ML, Pieters R, Hop WCJ, et al. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia. J Clin Oncol. 2011;29(31):4143–4150. doi:10.1200/JCO.2011.37.3217.
   PubMed Web of Science ®Google Scholar
• Mogensen SS, Harila-Saari A, Mäkitie O, et al. Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia. Pediatr Blood Cancer. 2018;65(10):e27300. doi:10.1002/pbc.27300.
   PubMed Web of Science ®Google Scholar
• Niinimäki T, Niinimäki J, Halonen J, Hänninen P, Harila-Saari A, Niinimäki R. The classification of osteonecrosis in patients with cancer: validation of a new radiological classification system. Clin Radiol. 2015;70(12):1439–1444. doi:10.1016/j.crad.2015.08.011.
   PubMed Web of Science ®Google Scholar
• Niinimäki T, Harila-Saari A, Niinimäki R. The diagnosis and classification of osteonecrosis in patients with childhood leukemia. Pediatr Blood Cancer. 2015;62(2):198–203. doi:10.1002/pbc.25295.
   PubMed Web of Science ®Google Scholar
• Schmiegelow K, Attarbaschi A, Barzilai S, Ponte di Legno toxicity working group, et al. Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus. Lancet Oncol. 2016;17(6):e231–e239. doi:10.1016/S1470-2045(16)30035-3.
   PubMed Web of Science ®Google Scholar
• Berbis J, Michel G, Baruchel A, et al. Cohort Profile: the French childhood cancer survivor study for leukaemia (LEA Cohort). Int J Epidemiol. 2015;44(1):49–57. doi:10.1093/ije/dyu031.
   PubMed Web of Science ®Google Scholar
• Jaramillo D. What is the optimal imaging of osteonecrosis, Perthes, and bone infarcts? Pediatr Radiol. 2009;39 Suppl 2:S216–S219. doi:10.1007/s00247-009-1151-7.
   PubMedGoogle Scholar
• Saini A, Saifuddin A. MRI of osteonecrosis. Clin Radiol. 2004;59(12):1079–1093. doi:10.1016/j.crad.2004.04.014.
   PubMed Web of Science ®Google Scholar
• Sapin C, Simeoni MC, El Khammar M, Antoniotti S, Auquier P. Reliability and validity of the VSP-A, a health-related quality of life instrument for ill and healthy adolescents. J Adolesc Health. 2005;36(4):327–336. doi:10.1016/j.jadohealth.2004.01.016.
   PubMed Web of Science ®Google Scholar
• Simeoni MC, Auquier P, Antoniotti S, Sapin C, San Marco JL. Validation of a French health-related quality of life instrument for adolescents: the VSP-A. Qual Life Res. 2000;9(4):393–403. doi:10.1023/a:1008957104322.
   PubMed Web of Science ®Google Scholar
• Simeoni MC, Sapin C, Antoniotti S, Auquier P. Health-related quality of life reported by French adolescents: a predictive approach of health status? J Adolesc Health. 2001;28(4):288–294. doi:10.1016/s1054-139x(00)00198-1.
   PubMed Web of Science ®Google Scholar
• Leplège A, Ecosse E, Verdier A, Perneger TV. The French SF-36 health survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol. 1998;51(11):1013–1023. doi:10.1016/s0895-4356(98)00093-6.
   PubMed Web of Science ®Google Scholar
• Berra S, Ravens-Sieberer U, Erhart M, et al. Methods and representativeness of a European survey in children and adolescents: the KIDSCREEN study. BMC Public Health. 2007;7:182. doi:10.1186/1471-2458-7-182.
   PubMed Web of Science ®Google Scholar
• Reulen RC, Zeegers MP, Jenkinson C, et al. The use of the SF-36 questionnaire in adult survivors of childhood cancer: evaluation of data quality, score reliability, and scaling assumptions. Health Qual Life Outcomes. 2006;4:77. doi:10.1186/1477-7525-4-77.
   PubMed Web of Science ®Google Scholar
• Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–174.
   PubMed Web of Science ®Google Scholar
• Oudot C, Auclerc MF, Levy V, et al. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study. J Clin Oncol. 2008;26(9):1496–1503. doi:10.1200/JCO.2007.12.2820.
   PubMed Web of Science ®Google Scholar
• Petit A, Ducassou S, Leblanc T, et al. Maintenance therapy with interleukin-2 for childhood AML: results of ELAM02 phase III randomized trial. Hemasphere. 2018;2(6):e159. doi:10.1097/HS9.0000000000000159.
   PubMed Web of Science ®Google Scholar
• Kunstreich M, Kummer S, Laws HJ, Borkhardt A, Kuhlen M. Osteonecrosis in children with acute lymphoblastic leukemia. Haematologica. 2016;101(11):1295–1305. doi:10.3324/haematol.2016.147595.
   PubMed Web of Science ®Google Scholar
• Barzilai-Birenboim S, Yacobovich J, Zalcberg Y, et al. Bone pain at leukemia diagnosis and other risk factors for symptomatic osteonecrosis in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2021;68(8):e29033. doi:10.1002/pbc.29033.
   PubMed Web of Science ®Google Scholar
• Inaba H, Cao X, Chang JY, et al. Incidence of hip and knee osteonecrosis and their associations with bone mineral density in children with acute lymphoblastic leukaemia. Br J Haematol. 2020;189(4):e177–e181. doi:10.1111/bjh.16589.
   PubMed Web of Science ®Google Scholar
• Amin N, Kinsey S, Feltbower R, et al. British OsteoNEcrosis Study (BONES) protocol: a prospective cohort study to examine the natural history of osteonecrosis in older children, teenagers and young adults with acute lymphoblastic leukaemia and lymphoblastic lymphoma. BMJ Open. 2019;9(5):e027204. doi:10.1136/bmjopen-2018-027204.
   PubMed Web of Science ®Google Scholar
• Hernigou P, Bachir D, Galacteros F. The natural history of symptomatic osteonecrosis in adults with sickle-cell disease. J Bone Joint Surg Am. 2003;85(3):500–504. doi:10.2106/00004623-200303000-00016.
   PubMedGoogle Scholar
• Kuhlen M, Kunstreich M, Gökbuget N. Osteonecrosis in adults with acute lymphoblastic leukemia: an unmet clinical need. Hemasphere. 2021;5(4):e544. doi:10.1097/HS9.0000000000000544.
   PubMed Web of Science ®Google Scholar
• Krez A, Lane J, Heilbronner A, et al. Risk factors for multi-joint disease in patients with glucocorticoid-induced osteonecrosis. Osteoporos Int. 2021;32(10):2095–2103. doi:10.1007/s00198-021-05947-x.
   PubMed Web of Science ®Google Scholar
• Kuhlen M, Kunstreich M, Krull K, Meisel R, Borkhardt A. Osteonecrosis in children and adolescents with acute lymphoblastic leukemia: a therapeutic challenge. Blood Adv. 2017;1(14):981–994. doi:10.1182/bloodadvances.2017007286.
   PubMed Web of Science ®Google Scholar
• Inaba H, Varechtchouk O, Neel MD, et al. Whole-joint magnetic resonance imaging to assess osteonecrosis in pediatric patients with acute lymphoblastic lymphoma. Pediatr Blood Cancer. 2020;67(8):e28336. doi:10.1002/pbc.28336.
   PubMed Web of Science ®Google Scholar
• Karol SE, Mattano LA, Yang W, et al. Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia. Blood. 2016;127(5):558–564. doi:10.1182/blood-2015-10-673848.
   PubMed Web of Science ®Google Scholar
• den Hoed MAH, Pluijm SMF, Uitterlinden AG, Pieters R, van den Heuvel-Eibrink MM. Genetic biomarkers to identify the risk of osteonecrosis in children with acute lymphoblastic leukemia. Mol Diagn Ther. 2016;20(6):519–522. doi:10.1007/s40291-016-0226-z.
   PubMed Web of Science ®Google Scholar